- Home
- CMPS vs POET Comparison
CMPS vs POET Comparison
Compare CMPS & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- POET
- Stock Information
- Founded
- CMPS 2020
- POET 1972
- Country
- CMPS United Kingdom
- POET Canada
- Employees
- CMPS N/A
- POET 90
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- POET Semiconductors
- Sector
- CMPS Health Care
- POET Technology
- Exchange
- CMPS Nasdaq
- POET Nasdaq
- Market Cap
- CMPS 364.9M
- POET 450.6M
- IPO Year
- CMPS 2020
- POET N/A
- Fundamental
- Price
- CMPS $3.68
- POET $7.17
- Analyst Decision
- CMPS Strong Buy
- POET Strong Buy
- Analyst Count
- CMPS 7
- POET 2
- Target Price
- CMPS $17.83
- POET $6.25
- AVG Volume (30 Days)
- CMPS 5.0M
- POET 2.6M
- Earning Date
- CMPS 07-31-2025
- POET 08-13-2025
- Dividend Yield
- CMPS N/A
- POET N/A
- EPS Growth
- CMPS N/A
- POET N/A
- EPS
- CMPS N/A
- POET N/A
- Revenue
- CMPS N/A
- POET $199,477.00
- Revenue This Year
- CMPS N/A
- POET $8,377.56
- Revenue Next Year
- CMPS N/A
- POET $1,061.73
- P/E Ratio
- CMPS N/A
- POET N/A
- Revenue Growth
- CMPS N/A
- POET N/A
- 52 Week Low
- CMPS $2.25
- POET $2.27
- 52 Week High
- CMPS $8.54
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- CMPS 50.85
- POET 77.29
- Support Level
- CMPS $2.25
- POET $5.10
- Resistance Level
- CMPS $3.50
- POET $7.28
- Average True Range (ATR)
- CMPS 0.31
- POET 0.56
- MACD
- CMPS 0.07
- POET 0.22
- Stochastic Oscillator
- CMPS 87.42
- POET 96.76
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.